Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome-Reference-Cited by-同舟云学术

Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome

Published:2019-01-14 Issue:1 Volume:19 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Romine Perrin E.,Martins Renato G.,Eaton Keith D.,Wood Douglas E.,Behnia Fatemeh,Goulart Bernardo H. L.,Mulligan Michael S.,Wallace Sarah G.,Kell Elizabeth,Bauman Julie E.,Patel Shilpen A.,Vesselle Hubert J.

Funder

Eli Lilly and Company

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-019-5284-2.pdf

Reference35 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30.

2. Sugimura H, Nichols FC, Yang P, Allen MS, Cassivi SD, Deschamps C, et al. Survival after recurrent non small-cell lung cancer after complete pulmonary resection. Ann Thorac Surg. 2007;83:409–17.

3. Lim E, Harris G, Patel A, Adachi I, Edmonds L, Song F. Preoperative versus postoperative chemotherapy in patients with resectable non-small cell lung cancer: systematic review and indirect comparison meta-analysis of randomized trials. J Thorac Oncol. 2009;4:1380–8.